What Is Stellate Ganglion Block

A stellate ganglion block (SGB) is a medical procedure in which a local anesthetic is injected near the stellate ganglion, a cluster of sympathetic nerve cell bodies located at the base of the neck alongside the C6 and C7 vertebrae. The injection temporarily interrupts sympathetic nerve signaling on that side of the body, producing a measurable reduction in fight-or-flight activation. Originally developed to treat complex regional pain syndrome and certain vascular conditions, it is now being explored for trauma-related disorders and chronic sympathetic overactivation.

The sympathetic nervous system governs the body's acute stress response: heart rate acceleration, blood vessel constriction, cortisol release, and heightened alertness. When this system becomes chronically overactivated, whether from psychological trauma, long-term stress, or neurological injury, it contributes to elevated inflammation, disrupted sleep, cardiovascular strain, and accelerated biological aging. Sustained sympathetic dominance is associated with increased allostatic load, a measure of cumulative physiological wear that correlates with earlier onset of age-related disease.

By temporarily silencing a major relay point in the sympathetic chain, a stellate ganglion block may allow the nervous system to recalibrate toward a less reactive baseline. This recalibration is relevant to longevity because autonomic balance, the interplay between sympathetic and parasympathetic branches, influences heart rate variability, immune regulation, and vascular health, all of which are markers tracked in longevity medicine. The procedure represents a targeted, short-duration intervention aimed at a root-level control system rather than a downstream symptom.

The stellate ganglion sits where the inferior cervical and first thoracic sympathetic ganglia fuse, forming a relay station for sympathetic nerve fibers that serve the head, neck, upper extremities, and heart. When a local anesthetic such as bupivacaine or ropivacaine is deposited around this ganglion under ultrasound or fluoroscopic guidance, it blocks the transmission of sympathetic impulses through that cluster. The blockade is temporary, lasting several hours at the pharmacological level, but the downstream effects on autonomic tone appear to outlast the anesthetic's direct action.

The leading hypothesis for why effects persist beyond the drug's half-life involves a concept sometimes called "sympathetic resetting." Chronic stress or trauma can upregulate nerve growth factor and increase the density of sympathetic nerve connections within the ganglion itself, creating a self-reinforcing loop of heightened sympathetic output. By interrupting this loop, the block may allow the ganglion to return to a lower baseline level of activity. Animal studies have shown that stellate ganglion blockade reduces norepinephrine levels in the brain and decreases amygdala reactivity, both of which are elevated in chronic stress states.

The procedure also affects immune signaling. The stellate ganglion modulates inflammatory cytokine production through its innervation of lymphoid tissue and blood vessels. Blocking it temporarily reduces pro-inflammatory signaling, which may contribute to improvements in conditions where neuroinflammation plays a role. Additionally, the shift toward parasympathetic dominance following the block is measurable through increases in heart rate variability, a biomarker that reliably tracks autonomic balance and is used across longevity and performance medicine.

The procedure is performed in an outpatient setting, typically in a pain clinic or procedure suite. You will lie on your back with your neck slightly extended. The practitioner uses an ultrasound probe to visualize the stellate ganglion and surrounding structures at the level of the C6 or C7 vertebra. After cleaning the skin and applying a small amount of local anesthetic to the surface, a thin needle is advanced under real-time imaging to the target. The injection of anesthetic (usually 5 to 10 milliliters of bupivacaine or ropivacaine) takes only a few minutes.

Within minutes of a successful block, you will likely notice warmth in the hand and arm on the injected side, a drooping eyelid, nasal congestion, and possibly slight hoarseness. These signs confirm that the ganglion has been blocked and typically resolve within two to four hours. Many people report a sense of calm or reduced mental chatter within the first day. You will be monitored for 30 to 60 minutes after the injection before being discharged. Most people return to normal activities within 24 hours, though strenuous exercise is typically avoided for a day or two.

A common initial approach involves one injection, followed by a reassessment at two to four weeks. If symptoms improve but do not fully resolve, a second injection (on the same or opposite side) may be performed. Some protocols call for a series of two to three injections spaced two to four weeks apart. For PTSD and chronic stress applications, many practitioners report that two treatments are sufficient for a sustained response, though this varies by individual.

The autonomic reset following a single block can last weeks to months. Some individuals experience lasting improvement from a single session, while others find that effects diminish over time and periodic retreatment is beneficial. There is no established upper limit on the number of blocks a person can receive, but diminishing returns after multiple treatments should prompt reevaluation of the underlying drivers of sympathetic overactivation.

Out-of-pocket costs for a stellate ganglion block typically range from $500 to $2,000 per injection in the United States, depending on the provider, geographic area, and imaging modality used. Some insurance plans cover the procedure when it is performed for FDA-recognized indications such as complex regional pain syndrome, but coverage for off-label uses like PTSD or anxiety varies widely. Military treatment facilities and certain VA hospitals offer the procedure to eligible veterans, sometimes at no cost. Longevity clinics that include SGB as part of a broader autonomic optimization package may charge at the higher end of this range or bundle it with additional assessments.

The evidence base for stellate ganglion block varies considerably by indication. For complex regional pain syndrome and certain neuropathic pain conditions, the procedure has decades of clinical use and is considered a standard intervention in pain medicine. For PTSD, the evidence is more recent and evolving. Several case series in military populations reported substantial reductions in PTSD Checklist scores, and a few randomized controlled trials have been completed, with results that trend positive but with sample sizes that remain modest. A multi-site randomized trial published in the early 2020s found that SGB produced clinically meaningful PTSD symptom reductions compared to sham injection, though the study had limitations including short follow-up duration.

Research into SGB for anxiety disorders, long COVID autonomic dysfunction, and hot flashes associated with menopause is in earlier stages, consisting mainly of case reports and small observational studies. Mechanistic work in animal models supports the biological plausibility of sympathetic resetting, and neuroimaging studies in humans have documented changes in amygdala activity and brain connectivity patterns following the block. The procedure lacks large-scale, long-duration randomized trials for most of its emerging applications, and there is no standardized protocol for dosing, laterality, or number of treatments. This limits the ability to draw firm conclusions about optimal use beyond its established pain indications.

The most common side effects are expected consequences of a successful block: Horner syndrome (drooping eyelid, constricted pupil, and reduced sweating on the affected side), temporary hoarseness from recurrent laryngeal nerve involvement, and a sensation of throat fullness. These resolve as the anesthetic wears off, typically within hours. Serious but uncommon complications include pneumothorax, hematoma, intravascular injection leading to seizure or cardiac arrhythmia, epidural or intrathecal spread of anesthetic, and nerve injury. The use of real-time ultrasound guidance has substantially reduced the incidence of these complications compared to landmark-based techniques. Individuals with bleeding disorders, active infection at the injection site, or severe cardiac conduction abnormalities should not undergo the procedure.